𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

✍ Scribed by Howard A. Cooper

Book ID
119270004
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
79 KB
Volume
56
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale and design of the dual antipla
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 307 KB
Rationale and design of the EMBRACE STEM
Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
✍ Chakrabarti, Anjan K.; Feeney, Kristin; Abueg, Cassandra; Brown, David A.; Czyz, πŸ“‚ Article πŸ“… 2013 πŸ› Elsevier Science 🌐 English βš– 322 KB